MicroPort Scientific Corporation: Coronary Artery Disease trials

The registry lists 15 Coronary Artery Disease studies with MicroPort Scientific Corporation as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 4 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)RecruitingNCT05961787Not applicable
• Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )CompletedNCT02688868Not applicableResults posted
• The First-In-Man Pilot Study of FirehawkCompletedNCT02688829Not applicableResults posted
• Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)CompletedNCT01412164Not applicableResults posted
• Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I TrialCompletedNCT01196819Not applicableResults posted
• TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS TreatmentActive, not recruitingNCT04951050Not applicable
• Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated LesionsActive, not recruitingNCT04918615Not applicable
• Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization StrategyCompletedNCT04753749Not applicable
• Firehawk Rapamycin Target Eluting Coronary Stent North American TrialActive, not recruitingNCT04562532Not applicable
• Trial for MicroPort's Firesorb BVS: FUTURE-IIIStatus unknownNCT03660202Not applicable
• Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery DiseaseStatus unknownNCT03287167Phase 4
• A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-IICompletedNCT02890160Not applicable
• A First-in-Man Study of the Firesorb BVS (FUTURE-I)CompletedNCT02659254Not applicable
• Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)CompletedNCT02520180Not applicable
• Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry TrialStatus unknownNCT00868829Not applicable